Study objectives | Outcome | Data collection method/tool | Time point of measurement | Analysis plan | ||
---|---|---|---|---|---|---|
Baseline (T0) | During intervention | Follow-up (T1) | Â | |||
1. Identify effective methods of recruiting individuals with T2DM | • # GP practices approached; # that agree to act as PIC • # individuals identified through GP database searches; response rate to information letters • # participants recruited from each recruitment setting • # individuals that consent to be part of the study | Study records | X |  |  | Frequencies and percentages |
2. Determine participants willingness to be randomized, study retention rates, adherence to the intervention and data collection methods and report harmful outcomes | • # participants retained in study following randomization • # Individuals that complete follow-up testing • # of participants that attend each of the intervention sessions and data collection sessions • # of harmful events | Study records |  | X |  | Frequencies and percentages |
3. Assess intervention fidelity | • # of training sessions attended by participants and additional contact with instructors • Extent to which intervention content is completed as planned | Intervention checklists |  | X |  | Frequencies and Percentages |
4. Estimate the potential effect of the intervention on a range of health and behaviour outcomes to inform outcome selection in future trials | • Weight, height, BMI | Tanita digital scales, SECA 700 | X |  | X | Comparison of change scores between conditions |
• Waist circumference | Non-stretch tape measure | X |  | X | ||
• Fasting glucose, insulin, lipids, C-reactive protein, HOMA-IR, HOMA-B | 8-mL blood sample | X |  | X | ||
• OGTT outcomes: iAUC for glucose and insulin, Matsuda index, insulinogenic index and oral glucose disposition index | 2 mL blood samples at 15, 30, 45, 60, 90, 120 min post 75 g of anhydrous glucose | X |  | X | Reporting of effect estimates with 95% CI | |
• Health-related quality of life: physical and mental summary | Short Form 36 Health Survey [39] | X |  | X | ||
• Cardiorespiratory fitness | Maximum oxygen uptake using cycle ergometer | X |  | X | ||
• Body composition: whole-body fat mass, regional fat mass, whole-body lean mass, regional fat mass | Dual-energy x-ray absorptiometry | X |  | X | Comparison of change scores between conditions | |
• Femur intermuscular adipose tissue, muscle density and muscle cross-sectional area | Peripheral quantitative computer tomography | |||||
• Total physical activity (time spent in moderate-to-vigorous physical activity) | Actigraph (GT3X) | X |  | X | Reporting of effect estimates with 95% CI | |
• Moderate to vigorous physical due to e-cycling and other modes of active travel | Actigraph (GT3X), Actiheart and QStarz GPS | |||||
• Transportation modes (walking, cycling, e-cycling, car, bus, train) | Actigraph (GT3X), Actiheart and QStarz GPS | X |  | X | ||
• Trip purpose (e.g., commuting, business, education, escorting, shopping, visiting friends, entertainment, recreation) | Travel diary | X |  | X | ||
• Estimated CO2 emissions | Actigraph (GT3X) and QStarz GPS, travel diary following procedures by Neves and Brand [48] | X |  | X | ||
• E-cycling behaviour: # journeys, distance travelled, pattern of e-bike use | Bike odometer and Garmin 130 GPS |  | X |  | Mean and SD | |
Qualitatively examine the acceptability of the intervention and study procedures to participants and instructors | • Acceptability of intervention to participants • Acceptability of study procedures to participants • Acceptability of intervention delivery to instructors | Semi-structured interviews |  |  | X | Thematic analysis based on objective |
Qualitatively examine participants experiences of e-cycling | • Participants barriers and facilitators to e-cycling | Semi-structured interviews |  |  | X | Thematic analysis based on objective |